A citation-based method for searching scientific literature


List of co-cited articles
869 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


From inflammation to sickness and depression: when the immune system subjugates the brain.
Robert Dantzer, Jason C O'Connor, Gregory G Freund, Rodney W Johnson, Keith W Kelley. Nat Rev Neurosci 2008
34

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.
Andrew H Miller, Vladimir Maletic, Charles L Raison. Biol Psychiatry 2009
31

A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
29

Cytokines sing the blues: inflammation and the pathogenesis of depression.
Charles L Raison, Lucile Capuron, Andrew H Miller. Trends Immunol 2006
25



Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
13

Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.
J C O'Connor, M A Lawson, C André, M Moreau, J Lestage, N Castanon, K W Kelley, R Dantzer. Mol Psychiatry 2009
730
12

Paroxetine for the prevention of depression induced by high-dose interferon alfa.
D L Musselman, D H Lawson, J F Gumnick, A K Manatunga, S Penna, R S Goodkin, K Greiner, C B Nemeroff, A H Miller. N Engl J Med 2001
728
11

Inflammation-associated depression: from serotonin to kynurenine.
Robert Dantzer, Jason C O'Connor, Marcus A Lawson, Keith W Kelley. Psychoneuroendocrinology 2011
431
10

Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression.
Charles L Raison, Andrey S Borisov, Matthias Majer, Daniel F Drake, Giuseppe Pagnoni, Bobbi J Woolwine, Gerald J Vogt, Breanne Massung, Andrew H Miller. Biol Psychiatry 2009
236
10

Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans.
Lena Brydon, Neil A Harrison, Cicely Walker, Andrew Steptoe, Hugo D Critchley. Biol Psychiatry 2008
207
10

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Charles L Raison, Robin E Rutherford, Bobbi J Woolwine, Chen Shuo, Pamela Schettler, Daniel F Drake, Ebrahim Haroon, Andrew H Miller. JAMA Psychiatry 2013
833
10

Immune system to brain signaling: neuropsychopharmacological implications.
Lucile Capuron, Andrew H Miller. Pharmacol Ther 2011
589
10

Cytokines and psychopathology: lessons from interferon-alpha.
Lucile Capuron, Andrew H Miller. Biol Psychiatry 2004
372
9

The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.
Jonas Hannestad, Nicole DellaGioia, Michael Bloch. Neuropsychopharmacology 2011
528
9

The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters.
Chong-Bin Zhu, Randy D Blakely, William A Hewlett. Neuropsychopharmacology 2006
337
9

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.
Stephen Tyring, Alice Gottlieb, Kim Papp, Ken Gordon, Craig Leonardi, Andrea Wang, Deepa Lalla, Michael Woolley, Angelika Jahreis, Ralph Zitnik,[...]. Lancet 2006
719
8

Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.
Lucile Capuron, Jane F Gumnick, Dominique L Musselman, David H Lawson, Andrea Reemsnyder, Charles B Nemeroff, Andrew H Miller. Neuropsychopharmacology 2002
494
8

Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment.
Lucile Capuron, Gabriele Neurauter, Dominique L Musselman, David H Lawson, Charles B Nemeroff, Dietmar Fuchs, Andrew H Miller. Biol Psychiatry 2003
315
8

Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin.
Jason C O'Connor, Caroline André, Yunxia Wang, Marcus A Lawson, Sandra S Szegedi, Jacques Lestage, Nathalie Castanon, Keith W Kelley, Robert Dantzer. J Neurosci 2009
306
8

Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration.
Lucile Capuron, Giuseppe Pagnoni, Daniel F Drake, Bobbi J Woolwine, James R Spivey, Ronald J Crowe, John R Votaw, Mark M Goodman, Andrew H Miller. Arch Gen Psychiatry 2012
209
8

Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats: role of nitric oxide as a signal crossing the blood-brain barrier.
Tomitsune Kitagami, Kiyofumi Yamada, Hideki Miura, Ryo Hashimoto, Toshitaka Nabeshima, Tatsurou Ohta. Brain Res 2003
83
9

Cytokine, sickness behavior, and depression.
Robert Dantzer. Immunol Allergy Clin North Am 2009
384
8


Cytokines as mediators of depression: what can we learn from animal studies?
Adrian J Dunn, Artur H Swiergiel, Renaud de Beaurepaire. Neurosci Biobehav Rev 2005
303
8

Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy.
Lucile Capuron, Giuseppe Pagnoni, Marina F Demetrashvili, David H Lawson, Fiona B Fornwalt, Bobbi Woolwine, Gregory S Berns, Charles B Nemeroff, Andrew H Miller. Neuropsychopharmacology 2007
162
7


Evidence for an immune response in major depression: a review and hypothesis.
M Maes. Prog Neuropsychopharmacol Biol Psychiatry 1995
684
7

Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?
Lucile Capuron, Fiona B Fornwalt, Bettina T Knight, Philip D Harvey, Philip T Ninan, Andrew H Miller. J Affect Disord 2009
112
7

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
N Müller, M J Schwarz, S Dehning, A Douhe, A Cerovecki, B Goldstein-Müller, I Spellmann, G Hetzel, K Maino, N Kleindienst,[...]. Mol Psychiatry 2006
506
7

The relationship of depression and stressors to immunological assays: a meta-analytic review.
E P Zorrilla, L Luborsky, J R McKay, R Rosenthal, A Houldin, A Tax, R McCorkle, D A Seligman, K Schmidt. Brain Behav Immun 2001
572
7


Anterior cingulate activation and error processing during interferon-alpha treatment.
Lucile Capuron, Giuseppe Pagnoni, Marina Demetrashvili, Bobbi J Woolwine, Charles B Nemeroff, Gregory S Berns, Andrew H Miller. Biol Psychiatry 2005
151
7

Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations.
Jennifer C Felger, Li Li, Paul J Marvar, Bobbi J Woolwine, David G Harrison, Charles L Raison, Andrew H Miller. Brain Behav Immun 2013
95
7

Cytokine-associated emotional and cognitive disturbances in humans.
A Reichenberg, R Yirmiya, A Schuld, T Kraus, M Haack, A Morag, T Pollmächer. Arch Gen Psychiatry 2001
847
7

Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.
Andrew H Miller, Ebrahim Haroon, Charles L Raison, Jennifer C Felger. Depress Anxiety 2013
357
7

Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure.
J D Salamone, R E Steinpreis, L D McCullough, P Smith, D Grebel, K Mahan. Psychopharmacology (Berl) 1991
289
7

Motivational states influence effort-based decision making in rats: the role of dopamine in the nucleus accumbens.
Bettina Mai, Susanne Sommer, Wolfgang Hauber. Cogn Affect Behav Neurosci 2012
59
11

Translational approaches to treatment-induced symptoms in cancer patients.
Robert Dantzer, Mary W Meagher, Charles S Cleeland. Nat Rev Clin Oncol 2012
89
7



Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment.
S J Bull, P Huezo-Diaz, E B Binder, J F Cubells, G Ranjith, C Maddock, C Miyazaki, N Alexander, M Hotopf, A J Cleare,[...]. Mol Psychiatry 2009
171
6

The inflammasome: pathways linking psychological stress, depression, and systemic illnesses.
Masaaki Iwata, Kristie T Ota, Ronald S Duman. Brain Behav Immun 2013
277
6

Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice.
M Pardo, L Lopez-Cruz, O Valverde, C Ledent, Y Baqi, C E Müller, J D Salamone, M Correa. Neuropharmacology 2012
77
7

The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure.
Allison M Mott, Eric J Nunes, Lyndsey E Collins, Russell G Port, Kelly S Sink, Jörg Hockemeyer, Christa E Müller, John D Salamone. Psychopharmacology (Berl) 2009
72
8

Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.
Annamaria Cattaneo, Massimo Gennarelli, Rudolf Uher, Gerome Breen, Anne Farmer, Katherine J Aitchison, Ian W Craig, Christoph Anacker, Patricia A Zunsztain, Peter McGuffin,[...]. Neuropsychopharmacology 2013
257
6

Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia.
Michael T Treadway, Nicholas A Bossaller, Richard C Shelton, David H Zald. J Abnorm Psychol 2012
302
6


The mysterious motivational functions of mesolimbic dopamine.
John D Salamone, Mercè Correa. Neuron 2012
678
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.